VETERANS AFFAIRS, DEPARTMENT OF has floated a tender for Pluvicto and Lutathera | VA GLA. The project location is USA and the tender is closing on 15 Aug 2025. The tender notice number is 36C26225Q1321, while the TOT Ref Number is 123991909. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Expired Tender

Procurement Summary

Country: USA

Summary: Pluvicto and Lutathera | VA GLA

Deadline: 15 Aug 2025

Other Information

Notice Type: Tender

TOT Ref.No.: 123991909

Document Ref. No.: 36C26225Q1321

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: Refer Document

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_details

Login to see details

Tender Details

Description

NOTICE OF INTENT TO SOLE SOURCE

This notice is being published in accordance with Federal Acquisition Regulation (FAR) Subpart 5.101 requiring dissemination of information for proposed contract actions. This is a notice of intent to award a sole source contract and is not a request for competitive quotes/proposals. The Department of Veterans Affairs, Network Contracting Office (NCO) 22, located at 4811 Airport Plaza Drive, Long Beach, CA is issuing this Notice of Intent (NOI) to inform industry contractors of the Government-s intent to execute a Sole Source Delivery Order under FAR Part 8, specifically FAR Part 8.405-6(a)(1)(B), Only One Available Source. The North American Industry Classification System (NAICS) for this requirement is 325412, Pharmaceutical Preparation Manufacturing. The Federal Supply Class (FSC) is 6505, Drugs and Biologicals. The Small Business Administration (SBA) size standard for this sector is 1, 300 Employees.

The intended contractor is Novartis Pharmaceuticals Corporation located at 59 Route 10, East Handover, NJ 07936. Place of Performance is the VA Greater Los Angeles Healthcare System located at 11301 Wilshire Blvd, Los Angeles, CA 90073. VA Greater Los Angeles Nuclear Medicine Service intends to purchase PLUVICTO LUTETIUM LU 177 VIPIVOTIDE TETRA 27mCi/ML and LUTATHERA LUTETIUM LU 177 DOTATATE in quantities listed below:

NDC#

Contract

Description

Qty

UOM

69488-0010-61

36F79720D0180

PLUVICTO LUTETIUM LU 177 VIPIVOTIDE TETRA 27mCi/ML

105

EA

69488-0003-01

36F79720D0180

LUTATHERA LUTETIUM LU 177 DOTATATE

10

EA



VA Greater Los Angele Healthcare System Nuclear Medicine Service requires Pluvicto to treat advance prostate cancer and Lutathera to treat neuroendocrine tumor therapy. Radiopharmaceuticals requested were awarded to Novartis Pharmaceuticals Corporations on 7/30/2020 under contract 36F79720D0180.

This notice of intent is neither a formal sol...
Active Contract Opportunity
Notice ID : 36C26225Q1321
Related Notice
Department/Ind. Agency : VETERANS AFFAIRS, DEPARTMENT OF
Sub-tier : VETERANS AFFAIRS, DEPARTMENT OF
Office: 262-NETWORK CONTRACT OFFICE 22 (36C262)
General Information
Contract Opportunity Type: Special Notice (Original)
Original Published Date: Aug 05, 2025 02:04 pm PDT
Original Response Date: Aug 15, 2025 10:00 am PDT
Inactive Policy: Manual
Original Inactive Date: Sep 05, 2025
Initiative: None

Classification
Original Set Aside: No Set aside used
Product Service Code: 6505 - DRUGS AND BIOLOGICALS
NAICS Code: 325412 - Pharmaceutical Preparation Manufacturing

Place of Performance: Los Angeles, CA 90073 USA

Documents

 Tender Notice

S02-36C26225Q1321.docx


Procurement Documents for USA

Access a comprehensive library of standard procurement documents specific to USA. Here, you'll find all the essential forms, guidelines, and templates required for tender applications and submissions in USA

Explore Procurement Documents for USA


Want To Bid in This Tender?

Get Local Agent Support in USA and 60 More Countries.

View All The Services


View Tenders By


Publish Tenders


Have Any Dispute With The Purchaser?